Matrix Metalloproteinase 7 in Rheumatoid Arthritis Patients with Interstitial Lung Disease | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 10, Volume 71, Issue 3, April 2018, Page 2697-2700 PDF (341.96 K) | ||||
| Document Type: Original Article | ||||
 View on SCiNiTO | ||||
| Author | ||||
| Howaida Elsayed Mansour, Sherin Mohamed Hosny, Nermeen Samy Khalel, Hana Muhammed Abdulsalam | ||||
| Faculty of Medicine–Ain Shams University | ||||
| Abstract | ||||
| The study aim: The purpose of this study is to measure the matrix metalloproteinase 7 (MMP7) in rheumatoid arthritis (RA) patients with interstitial lung disease (ILD) and to assess for any correlation with RA-disease activity. Research design: A cross sectional study. Sample: a purposive sample included 40 rheumatoid arthritis patients from Ain Shams University Hospitals Inpatient Department of Rheumatology and Outpatient Clinic. The results revealed that serum (S) MMP7 was significantly higher among RA patients with interstitial lung disease than patients without. Conclusion: The study documented that S.MMP7 may be used as a screening test for detection of interstitial lung disease in patients with rheumatoid arthritis. The study recommended: Measurement of serum MMP7 level to RA patients may be used as screening test for detection of ILD | ||||
| Keywords | ||||
| RA: Rheumatoid arthritis. MMP7: Matrix metalloproteinase 7. ILD: Interstitial lung disease | ||||
|
Statistics Article View: 100 PDF Download: 229 |
||||
